(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
0.34% CNY 41.73
Live Chart Being Loaded With Signals
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer...
Stats | |
---|---|
Volumen de hoy | 5.84M |
Volumen promedio | 5.97M |
Capitalización de mercado | 17.46B |
EPS | CNY0.370 ( 2023-10-24 ) |
Próxima fecha de ganancias | ( CNY0.230 ) 2024-05-15 |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 44.39 |
ATR14 | CNY0.0350 (0.08%) |
Volumen Correlación
Betta Pharmaceuticals Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Betta Pharmaceuticals Correlación - Moneda/Commodity
Betta Pharmaceuticals Finanzas
Annual | 2023 |
Ingresos: | CNY2.44B |
Beneficio Bruto: | CNY1.88B (76.84 %) |
EPS: | CNY0.830 |
FY | 2023 |
Ingresos: | CNY2.44B |
Beneficio Bruto: | CNY1.88B (76.84 %) |
EPS: | CNY0.830 |
FY | 2022 |
Ingresos: | CNY2.38B |
Beneficio Bruto: | CNY2.11B (88.69 %) |
EPS: | CNY0.350 |
FY | 2021 |
Ingresos: | CNY2.25B |
Beneficio Bruto: | CNY2.07B (92.23 %) |
EPS: | CNY0.950 |
Financial Reports:
No articles found.
Betta Pharmaceuticals
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer. Betta Pharmaceuticals Co., Ltd. was founded in 2003 and is headquartered in Hangzhou, China.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico